Valneva SE (VALN)
$5.69-3.07%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $540M
- Beta
- 1.35
- P/E (TTM)
- -2.85
- Short % float
- 0.21%
- Days to cover
- 4.8
- SI change
- -1.2%
- 1W
- -3.56%
- 1M
- -14.82%
- vs SPY 1W
- -5.12%
- vs SPY 1M
- -16.58%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$6.3BRECOVERYQ 8$14.15+3.02%
- MBXSELLMBX Biosciences, Inc. Common Stock$2.8BCRISISQ 38$58.54-2.37%
- DAWNDay One Biopharmaceuticals, Inc.$2.2B$21.53
- AVBPSELLArriVent BioPharma, Inc.$1.3BCRISISQ -5$28.46-1.07%
- REPLSELLReplimune Group, Inc.$1.1BRECOVERYQ 14$13.15-1.21%
- MGTXSELLMeiraGTx Holdings plc$1.0BCRISISQ 6$10.92-2.96%
- DNABUYGinkgo Bioworks Holdings, Inc.$979MCRISISQ -17$14.98-1.13%
- GERNSELLGeron Corporation$776MRECOVERYQ 11$1.21+1.67%
- ATXSAstria Therapeutics, Inc.$718M$12.58
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 26
- VALUE
- 16
- GROWTH
- 14
- GARP
- 80
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-91.3%
REV YoY-
ROE-152.1%
EPS YoY-
ROA-40.6%
GROSS16
OP-87
NET-110
[VALUATION]
P/E TTM-2.85
P/E FWD11.39
SECTOR PE20.12
INDUSTRY PE13.79
P/B6.00
P/FCF-
EV/EBITDA-5.59
EV/EBIT-
PEG0.31
FCF YIELD-
RISK
INT COV-
D/E259.16
ALTMAN Z-
CURR RATIO2.16
ND/EBITDA-
BETA1.35
